Data coverage, completeness and provenance for PARADIGM BIOPHARMACEUTICALS LIMITED.. in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-09-18T06:10:25. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.2450 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.2450 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.2450 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.2450 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.2450 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/PAR/prices · Price parameters and adjustment semantics
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Website: https://www.paradigmbiopharma.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/PAR/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 30 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 28 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 27 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 26 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/PAR
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/PAR/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/PAR/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/PAR/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/PAR/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PAR
Free tier — instant API key. Built for AI agents.